在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

EPHB6 Antibody, FITC conjugated

  • 中文名稱:
    EPHB6兔多克隆抗體, FITC偶聯
  • 貨號:
    CSB-PA007733LC01HU
  • 規格:
    ¥880
  • 其他:

產品詳情

  • 產品名稱:
    Rabbit anti-Homo sapiens (Human) EPHB6 Polyclonal antibody
  • Uniprot No.:
  • 基因名:
    EPHB6
  • 別名:
    EPH receptor B6 antibody; Ephb6 antibody; EPHB6_HUMAN antibody; Ephrin type B receptor 6 precursor antibody; Ephrin type-B receptor 6 antibody; HEP antibody; MGC129910 antibody; MGC129911 antibody; Tyrosine protein kinase defective receptor EPH 6 antibody; Tyrosine-protein kinase-defective receptor EPH-6 antibody
  • 宿主:
    Rabbit
  • 反應種屬:
    Human
  • 免疫原:
    Recombinant Human Ephrin type-B receptor 6 protein (410-553AA)
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標記方式:
    FITC
  • 克隆類型:
    Polyclonal
  • 抗體亞型:
    IgG
  • 純化方式:
    >95%, Protein G purified
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
  • 產品提供形式:
    Liquid
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 功能:
    Kinase-defective receptor for members of the ephrin-B family. Binds to ephrin-B1 and ephrin-B2. Modulates cell adhesion and migration by exerting both positive and negative effects upon stimulation with ephrin-B2. Inhibits JNK activation, T-cell receptor-induced IL-2 secretion and CD25 expression upon stimulation with ephrin-B2.
  • 基因功能參考文獻:
    1. using an EphB6 mouse knockout model we found that the loss of EphB6 does not initiate intestinal tumorigenesis and is not involved in the early tumor progression through the adenoma-to-carcinoma transition. PMID: 28262839
    2. Data indicate that EphB6 protein was decreased in gastric carcinoma compared with normal mucosa. Analytic results based on pathological parameters suggests that EphB6 protein may inhibit metastasis of gastric carcinoma. PMID: 28453458
    3. Authors provide evidence that an intrinsically kinase-inactive member of the Eph group of receptor tyrosine kinases, EPHB6, induces marked fragmentation of the mitochondrial network in breast cancer cells of triple-negative origin, lacking expression of the estrogen, progesterone and HER2 receptors. PMID: 27788485
    4. SRC kinase is a synthetic lethality partner of EPHB6 in triple-negative breast cancer cells PMID: 27418135
    5. Study is the first to demonstrate that EphB6 overexpression together with Apc gene mutations may enhance proliferation, invasion and metastasis by colorectal epithelial cells. PMID: 27145271
    6. Melanomas from geographically different regions in New Zealand have markedly different mutation frequencies, in particular in the NRAS and EPHB6 genes, when compared to The Cancer Genome Atlas database or other populations. These data have implications for the causation and treatment of malignant melanoma in New Zealand. PMID: 27191502
    7. Low EPHB6 expression is associated with prostate cancer metastasis. PMID: 28826721
    8. Enhanced EphB6 expression was significantly associated with Thyroid Lesions. PMID: 26220827
    9. EphB6 protein may be used as a new marker for prognosis for tongue squamous cell carcinoma. PMID: 26617870
    10. EphB6 is a new biomarker for distinguishing high- and low-grade ovarian serous carcinoma, and may be a potential prognostic marker in ovarian serous carcinomas. PMID: 26468391
    11. EphB6 also interacts with the Hsp90 chaperone. PMID: 25152371
    12. We demonstrate that EphB6 reexpression forces metastatic melanoma cells to deviate from the canonical migration pattern observed in the chick embryo transplant model PMID: 24836890
    13. Results suggest that erythropoietin-producing hepatocyte (Eph) receptor B6 (EphB6) may represent a useful tissue biomarker for the prediction of survival rate in colorectal cancers (CRCs). PMID: 24912672
    14. Studies clearly demonstrate an inverse relationship between the levels of phospho-ERK and the abundance of cadherin 17, beta-catenin and phospho-GSK3beta in EPHB6-expressing MDA-MB-231 cells. PMID: 25331796
    15. The alterations in miRNAs and their target mRNAs also suggest indirect involvement of EphB6 in PI3K/Akt/mTOR pathways. PMID: 21811619
    16. results indicate that tumor invasiveness-suppressing activity of EPHB6 is mediated by its ability to sequester other kinase-sufficient and oncogenic EPH receptors PMID: 21737611
    17. Nonsynonymous variants of EPHB6 is associated with familial colorectal cancer. PMID: 21351276
    18. expression of more than 70 proteins was altered in EphB6-transfected MDA-MB-231 cells; proteins are involved in glycolysis, cell cycle regulation, tumor suppression, cell proliferation, mitochondrial metabolism, mRNA splicing, DNA replication and repair PMID: 20952760
    19. The loss of EPHB6 expression in more aggressive breast carcinoma cell lines is regulated in a methylation-dependent manner. The EPHB6 methylation-specific PCR has clinical implications for the prognosis and/or diagnosis of breast and other cancer types PMID: 20181626
    20. Findings suggest a new role for EphB6 in suppressing cancer invasiveness and cell attachment through c-Cbl-dependent signaling. PMID: 20086179
    21. interaction between EphB6 and its ligands facilitates T cell responses to antigen PMID: 12393850
    22. EphB6 may play an important role in regulating thymocyte differentiation and modulating responses of mature T cells. PMID: 12517763
    23. lower EphB6 expression has a role in melanoma progression to metastatic disease PMID: 14612926
    24. EphB6 can both positively and negatively regulate cell adhesion and migration PMID: 15955811
    25. The potential significance of EphB6 to serve as a diagnostic and prognostic indicator is discussed. PMID: 16364251
    26. the two peptides derived from EphB6v might be appropriate targets for peptide-based specific immunotherapy for HLA-A2(+) patients with various cancers PMID: 18754880
    27. EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells. PMID: 19234485
    28. The kinase defective EPHB6 receptor tyrosine kinase activates MAP kinase signaling in lung adenocarcinoma. PMID: 19513565
    29. Cross-linking of EphB6 alters profiles of lymphokine secretion, inhibits proliferation, induces Fas-mediated apoptosis of Jurkat leukemic T cells, and transduces signals into the cells via proteins it associates with. PMID: 11466354

    顯示更多

    收起更多

  • 亞細胞定位:
    Membrane; Single-pass type I membrane protein.; [Isoform 3]: Secreted.
  • 蛋白家族:
    Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily
  • 組織特異性:
    Expressed in brain. Expressed in non invasive breast carcinoma cell lines (at protein level). Strong expression in brain and pancreas, and weak expression in other tissues, such as heart, placenta, lung, liver, skeletal muscle and kidney. Expressed in bre
  • 數據庫鏈接:

    HGNC: 3396

    OMIM: 602757

    KEGG: hsa:2051

    STRING: 9606.ENSP00000376684

    UniGene: Hs.380089



主站蜘蛛池模板: 韩国无码av片在线观看| 色欲av伊人久久大香线蕉影院| 久久精品青青草原伊人| 久久久久高潮毛片免费全部播放| 漂亮人妻被黑人久久精品| 日本被黑人强伦姧人妻完整版| 狠狠色综合网久久久久久| 永久黄网站免费视频性色| 亚洲 欧洲 日韩 综合色天使| 国产成人综合日韩精品无码不卡| 亚洲男人第一av网站| 蜜桃视频一区二区在线观看| 久久亚洲精品无码播放| 中文成人无码精品久久久动漫 | 亚洲国产精品久久久久秋霞影院| 成年轻人电影www无码| 一区二区视频传媒有限公司| 在线天堂最新版资源| 美女大量吞精在线观看456| 中文在线а√天堂官网| 欧美国产伦久久久久久久| 成人亚洲国产精品一区不卡| 伊人久久久精品区aaa片| 国产亚洲精品久久久久小| 亚洲v欧美v日韩v国产v| 制服 丝袜 人妻 专区一本| аⅴ天堂中文在线网官网| 男女啪啪无遮挡免费网站| 怡红院一区二区三区在线| 亚洲精品乱码久久久久久日本 | 国产日产欧产精品精品推荐免费| 国产成人亚洲综合图区| 男女下面一进一出无遮挡 | 精品午夜福利在线视在亚洲| 精品国产成人网站一区在线| 国产成人精品无码一区二区| 99j久久精品久久久久久| 亚洲国产精品自在拍在线播放蜜臀| 五十路熟女一区二区三区| 青青国产线免观| 久久99亚洲含羞草影院|